Agenus Company Leadership

AGEN Stock  USD 1.78  0.05  2.89%   
Agenus' insiders are aggressively buying. The analysis of the overall insider sentiment regarding Agenus Inc suggests that virtually all insiders are extremely bullish. Agenus employs about 389 people. The company is managed by 20 executives with a total tenure of roughly 45 years, averaging almost 2.0 years of service per executive, having 19.45 employees per reported executive.
Garo Armen  Chairman
Founder, Executive Chairman, CEO and Chairman of Bus. and Devel. Advisory Committee

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2024-02-15Garo H ArmenAcquired 25000 @ 13View
2023-10-16Agenus IncAcquired 21 @ 22View
2023-10-12Agenus IncAcquired 158 @ 22View
2023-10-04Agenus IncAcquired 750 @ 21.8View
2023-08-28Agenus IncAcquired 640 @ 29View
2023-08-24Agenus IncAcquired 8512 @ 30.8View
2023-05-10Agenus IncAcquired 1103 @ 30.2View
2023-05-05Agenus IncAcquired 5010 @ 19View
2023-05-03Agenus IncAcquired 6434 @ 21.6View
Monitoring Agenus' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Agenus Management Team Effectiveness

The company has return on total asset (ROA) of (0.2195) % which means that it has lost $0.2195 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.7883) %, meaning that it created substantial loss on money invested by shareholders. Agenus' management efficiency ratios could be used to measure how well Agenus manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of March 2025, Return On Tangible Assets is likely to drop to -1.2. In addition to that, Return On Capital Employed is likely to grow to -23.5. At this time, Agenus' Fixed Asset Turnover is very stable compared to the past year. As of the 19th of March 2025, Asset Turnover is likely to grow to 0.48, while Non Currrent Assets Other are likely to drop about 3.5 M.
As of the 19th of March 2025, Common Stock Shares Outstanding is likely to grow to about 21.6 M, though Net Loss is likely to grow to (188.3 M).

Agenus Workforce Comparison

Agenus Inc is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 2,633. Agenus retains roughly 389 in number of employees claiming about 15% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.42) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.33.

Agenus Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agenus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agenus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Agenus insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Agenus Notable Stakeholders

An Agenus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Agenus often face trade-offs trying to please all of them. Agenus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Agenus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Garo ArmenFounder, Executive Chairman, CEO and Chairman of Bus. and Devel. Advisory CommitteeProfile
Jennifer BuellDirector TherapeuticsProfile
Christine KlaskinPrincipal Accounting Officer and VP of Fin.Profile
Julie DeSanderChief OfficerProfile
Alfred DadsonChief OfficerProfile
Eric HumesChief OfficerProfile
Regina GreblaVP CommunicationsProfile
Dr MBAChief OfficerProfile
John CastleHead BioinformaticsProfile
Zack ArmenHead DevelopmentProfile
Dhan ChandScientific DiscoveryProfile
Divya VasudevanSenior RelationsProfile
Nils MDChief OfficerProfile
Tracy ClementeChief OfficerProfile
Burcu YigitScientist IIProfile
Todd MDMember AdvisorProfile
Craig WinterChief OfficerProfile
Robin JDChief OfficerProfile
Stephanie FaganChief OfficerProfile
Stefanie PernaNacarChief OfficerProfile

About Agenus Management Performance

The success or failure of an entity such as Agenus Inc often depends on how effective the management is. Agenus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Agenus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Agenus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.14)(1.20)
Return On Capital Employed(24.74)(23.50)
Return On Assets(1.00)(1.05)
Return On Equity 0.70  0.58 

Agenus Workforce Analysis

Traditionally, organizations such as Agenus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Agenus within its industry.

Agenus Manpower Efficiency

Return on Agenus Manpower

Revenue Per Employee401.8K
Revenue Per Executive7.8M
Net Loss Per Employee631.8K
Net Loss Per Executive12.3M
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.02)
Revenue Per Share
7.808
Quarterly Revenue Growth
0.033
Return On Assets
(0.22)
Return On Equity
(12.79)
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.